New Bed Bug Bully Spray Promises Easy Bed Bug Treatment with Big…

OptimalChemical.com recently made available to the public its new Bed Bug Bully. The product, made of natural ingredients, promises an easy, affordable and safe bed bug treatment.

(PRWeb June 27, 2012)

Read the full story at http://www.prweb.com/releases/2012/6/prweb9644548.htm

Drug Patent Expirations for Jun 18 2012

If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations body { font-family:Calibri, tahoma, arial, sans-serif;}table { font-size:12px; font-family:Calibri, tahoma, arial, sans-serif; border-collapse:collapse; margin: 0px auto;}.xsnazzy h1, .zsnazzy h1 { margin:0; font-size:1.2em; padding:0 10px 5px 10px; border-bottom:1px solid #444; }.xsnazzy { background: transparent; margin:0 3px;}.xtop, .xbottom { display:block; background:transparent; font-size:1px; }.xb1, .xb2, .xb3, .xb4 { display:block; overflow:hidden; }.xb1, .xb2, .xb3 { height:1px; }.xb2, .xb3, .xb4 { background:#fff; border-left:1px solid #444; border-right:1px solid #444; }.xb1 { margin:0 5px; background:#444; }.xb2 { margin:0 3px; border-width:0 2px; }.xb3 { margin:0 2px; }.xb4 { height:2px; margin:0 1px;}.xboxcontent { display:block; border:0 solid #444; border-width:0 1px; height:auto; }* html .xboxcontent { height:1px; } td { padding:3px; } tr { border:.5pt; background-color:#FFF; }

ADVERTISE HERE

This newsletter is a free service of DrugPatentWatch
DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents

Simple flat-rate database subscription plans Ultimate Plan Premium Plan Basic Plan One year $1,995 $1,795 $1,095 One month $525 $425 $325 48 hours $95 $75 Plan comparison    Site tour    Contact

Drug Patent Expirations for Jun 18 2012 Tradename Applicant Generic Name Patent Number Patent Expiration EPZICOM Viiv Hlthcare abacavir sulfate; lamivudine 5,034,394*PED Jun 18, 2012 TRIZIVIR Viiv Hlthcare abacavir sulfate; lamivudine; zidovudine 5,034,394*PED Jun 18, 2012 ZIAGEN Viiv Hlthcare abacavir sulfate 5,034,394*PED Jun 18, 2012 *Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details. DrugPatentWatch Serves Your Competitive Intelligence Needs Subscribers have access to valuable datasets, including: Clinical trial information International patent families International patent priority and PCT information Patent maintenance Full-text patent downloads Sales data (top 200 drugs) Paragraph IV challenges Tentative approvals Dynamic search capabilities with data export More… See the Database Preview and Plan Comparison. Contact Us with any questions.

---